1.
Sarhan AS, Naji AS. Clinical Outcomes and Safety of Pembrolizumab Monotherapy in Iraqi Patients with Metastatic Lung Cancer and Renal Cell Carcinoma. MECOJ [Internet]. 2026 Jun. 25 [cited 2026 Oct. 28];2(2):59-66. Available from: https://scientificsteps-group.com/ojs/ojs3/index.php/mecoj/article/view/228